About Sirtex
Sirtex is a company based in Sydney (Australia) founded in 1991 was acquired by CDH in June 2018. It operates as a Direct-to-Consumer (D2C), and Professional Services. Sirtex has completed 1 acquisition, including OncoSec Medical. Sirtex offers products and services including SIR-Spheres Y-90 Resin Microspheres, LAVA Liquid Embolic System, and SIROS INSYTE with SurePlan LiverY90. Sirtex operates in a competitive market with competitors including RefleXion, Alpha Tau Medical, Mevion Medical Systems, ZAP-X and ABK Biomedical, among others.
- Headquarter Sydney, Australia
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sirtex Medical Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
CDH
(Jun 14, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sirtex
Sirtex offers a comprehensive portfolio of products and services, including SIR-Spheres Y-90 Resin Microspheres, LAVA Liquid Embolic System, and SIROS INSYTE with SurePlan LiverY90. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Used for treating unresectable liver tumors and metastases.
Designed for embolization in various medical treatment procedures.
Supports planning and delivery of liver cancer treatments.
Unlock access to complete
Sales and Marketing
39 people
Leadership Team
12 people
Software Development Team
6 people
Senior Team
6 people
Human Resources and Administration
3 people
Finance and Accounting
2 people
Operations Team
2 people
Market Team
2 people
Unlock access to complete
Funding Insights of Sirtex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sirtex
Sirtex has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include China Grand Pharmaceutical and Healthcare and CDH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and private debt firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Finished formulations and APIs are manufactured for therapeutic categories.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sirtex
Sirtex has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OncoSec Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Intratumoral immunotherapies are developed to harness immune responses against cancer.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Sirtex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sirtex Comparisons
Competitors of Sirtex
Sirtex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RefleXion, Alpha Tau Medical, Mevion Medical Systems, ZAP-X and ABK Biomedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biology-guided radiotherapy systems are provided for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Radiotherapy technique for solid tumors is developed using alpha-emitting seeds.
|
|
| domain | founded_year | HQ Location |
Proton therapy systems are supplied for cancer radiation treatment.
|
|
| domain | founded_year | HQ Location |
Developer of gyroscopic radiosurgery platform
|
|
| domain | founded_year | HQ Location |
Imageable embolic devices are developed for hypervascular tumors.
|
|
| domain | founded_year | HQ Location |
Targeted radiopharmaceuticals are developed for solid tumor treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sirtex
Frequently Asked Questions about Sirtex
When was Sirtex founded?
Sirtex was founded in 1991.
Where is Sirtex located?
Sirtex is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
What does Sirtex do?
Sirtex is focused on the development and distribution of innovative medical devices for the treatment of liver cancer and related conditions. The company specializes in products like SIR-Spheres Y-90 Resin Microspheres for treating unresectable liver tumors and metastases, alongside other solutions such as the LAVA Liquid Embolic System for embolization procedures. Operating in the healthcare sector, Sirtex serves professionals and patients globally through offices in the United States, Australia, Germany, and Singapore. Their offerings are tailored to address critical needs in oncology, providing targeted therapies and support for complex medical challenges.
Who are the top competitors of Sirtex?
Sirtex's top competitors include RefleXion, Alpha Tau Medical and Starget Pharma.
What products or services does Sirtex offer?
Sirtex offers SIR-Spheres Y-90 Resin Microspheres, LAVA Liquid Embolic System, and SIROS INSYTE with SurePlan LiverY90.
How many acquisitions has Sirtex made?
Sirtex has made 1 acquisition, including OncoSec Medical.
Who are Sirtex's investors?
Sirtex has 2 investors. Key investors include China Grand Pharmaceutical and Healthcare, and CDH.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.